News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
715,804 Results
Type
Article (42392)
Company Profile (264)
Press Release (673147)
Multimedia
Podcasts (65)
Webinars (14)
Section
Business (207076)
Career Advice (2072)
Deals (35879)
Drug Delivery (98)
Drug Development (81733)
Employer Resources (173)
FDA (16437)
Job Trends (15183)
News (350091)
Policy (33281)
Tag
Academia (2642)
Academic (1)
Accelerated approval (10)
Adcomms (22)
Allergies (96)
Alliances (50580)
ALS (110)
Alzheimer's disease (1460)
Antibody-drug conjugate (ADC) (151)
Approvals (16433)
Artificial intelligence (317)
Autoimmune disease (28)
Automation (19)
Bankruptcy (365)
Best Places to Work (11738)
BIOSECURE Act (19)
Biosimilars (123)
Biotechnology (180)
Bladder cancer (93)
Brain cancer (34)
Breast cancer (366)
Cancer (2890)
Cardiovascular disease (217)
Career advice (1734)
Career pathing (31)
CAR-T (185)
CDC (30)
Cell therapy (501)
Cervical cancer (23)
Clinical research (67239)
Collaboration (1026)
Company closure (3)
Compensation (690)
Complete response letters (23)
COVID-19 (2689)
CRISPR (59)
C-suite (333)
Cystic fibrosis (113)
Data (3022)
Decentralized trials (2)
Denatured (25)
Depression (61)
Diabetes (347)
Diagnostics (6605)
Digital health (23)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (139)
Drug pricing (124)
Drug shortages (28)
Duchenne muscular dystrophy (130)
Earnings (88023)
Editorial (40)
Employer branding (22)
Employer resources (149)
Events (114726)
Executive appointments (852)
FDA (18100)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (944)
Gene editing (134)
Generative AI (22)
Gene therapy (379)
GLP-1 (795)
Government (4559)
Grass and pollen (4)
Guidances (182)
Healthcare (19014)
HIV (41)
Huntington's disease (30)
IgA nephropathy (39)
Immunology and inflammation (148)
Immuno-oncology (9)
Indications (39)
Infectious disease (2865)
Inflammatory bowel disease (150)
Inflation Reduction Act (12)
Influenza (63)
Intellectual property (120)
Interviews (318)
IPO (16681)
IRA (46)
Job creations (3837)
Job search strategy (1473)
Kidney cancer (13)
Labor market (52)
Layoffs (501)
Leadership (19)
Legal (8152)
Liver cancer (79)
Longevity (11)
Lung cancer (405)
Lymphoma (209)
Machine learning (11)
Management (58)
Manufacturing (390)
MASH (92)
Medical device (13552)
Medtech (13557)
Mergers & acquisitions (19921)
Metabolic disorders (854)
Multiple sclerosis (97)
NASH (17)
Neurodegenerative disease (118)
Neuropsychiatric disorders (32)
Neuroscience (2141)
NextGen: Class of 2025 (6579)
Non-profit (4551)
Now hiring (47)
Obesity (430)
Opinion (228)
Ovarian cancer (101)
Pain (108)
Pancreatic cancer (122)
Parkinson's disease (187)
Partnered (22)
Patents (302)
Patient recruitment (167)
Peanut (51)
People (58578)
Pharmaceutical (65)
Pharmacy benefit managers (21)
Phase I (20948)
Phase II (29569)
Phase III (22063)
Pipeline (1648)
Policy (202)
Postmarket research (2617)
Preclinical (8997)
Press Release (67)
Prostate cancer (141)
Psychedelics (37)
Radiopharmaceuticals (254)
Rare diseases (462)
Real estate (6166)
Recruiting (67)
Regulatory (23059)
Reports (50)
Research institute (2397)
Resumes & cover letters (360)
Rett syndrome (9)
RNA editing (8)
RSV (49)
Schizophrenia (86)
Series A (159)
Series B (108)
Service/supplier (11)
Sickle cell disease (60)
Special edition (18)
Spinal muscular atrophy (149)
Sponsored (35)
Startups (3645)
State (2)
Stomach cancer (14)
Supply chain (76)
Tariffs (57)
The Weekly (38)
Vaccines (793)
Venture capital (54)
Weight loss (259)
Women's health (47)
Worklife (16)
Date
Today (74)
Last 7 days (346)
Last 30 days (1858)
Last 365 days (31372)
2025 (16962)
2024 (35452)
2023 (40366)
2022 (51478)
2021 (56086)
2020 (54545)
2019 (47055)
2018 (35410)
2017 (32601)
2016 (32076)
2015 (38092)
2014 (32004)
2013 (27149)
2012 (29221)
2011 (29926)
2010 (27991)
Location
Africa (754)
Alabama (61)
Alaska (7)
Arizona (246)
Arkansas (13)
Asia (39254)
Australia (6434)
California (7490)
Canada (2374)
China (676)
Colorado (322)
Connecticut (320)
Delaware (192)
Europe (85147)
Florida (1123)
Georgia (249)
Hawaii (1)
Idaho (59)
Illinois (642)
India (27)
Indiana (362)
Iowa (17)
Japan (229)
Kansas (109)
Kentucky (29)
Louisiana (14)
Maine (64)
Maryland (1032)
Massachusetts (5562)
Michigan (246)
Minnesota (456)
Mississippi (3)
Missouri (96)
Montana (31)
Nebraska (25)
Nevada (81)
New Hampshire (66)
New Jersey (2090)
New Mexico (29)
New York (2098)
North Carolina (1102)
North Dakota (8)
Northern California (3287)
Ohio (242)
Oklahoma (16)
Oregon (34)
Pennsylvania (1622)
Puerto Rico (17)
Rhode Island (37)
South America (1136)
South Carolina (35)
South Dakota (1)
Southern California (2808)
Tennessee (126)
Texas (1133)
United States (27777)
Utah (222)
Virginia (187)
Washington D.C. (72)
Washington State (638)
West Virginia (4)
Wisconsin (67)
715,804 Results for "upsher smith laboratories inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
PANTHERx® Rare Selected by Upsher-Smith Laboratories, LLC as Specialty Pharmacy for VIGAFYDE™ (vigabatrin) Oral Solution
March 25, 2025
·
3 min read
Press Releases
UPSHER-SMITH SHOWCASES ITS COMMITMENT TO DUCHENNE MUSCULAR DYSTROPHY COMMUNITY AS A TRUSTED PARTNER IN PEDIATRIC RARE DISEASES AT THE PARENT PROJECT MUSCULAR DYSTROPHY (PPMD) 2025 ANNUAL CONFERENCE
June 17, 2025
·
6 min read
Press Releases
UPSHER-SMITH TO SHOWCASE RARE DISEASE PORTFOLIO AT 2025 AAN ANNUAL MEETING
April 7, 2025
·
21 min read
BioMidwest
UPSHER-SMITH LAUNCHES METHIMAZOLE TABLETS, USP
Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the recent launch of Methimazole Tablets, USP, 5 mg and 10 mg. The Methimazole Tablet market had U.S. sales of approximately $36.8 million for the 12 months ending December 2023 according to IQVIA.
March 29, 2024
·
1 min read
BioMidwest
UPSHER-SMITH PREVIEWS EXPANSION OF ITS RARE DISEASE PORTFOLIO AT 2024 AAN ANNUAL MEETING
Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it will be participating in the 2024 American Academy of Neurology (AAN) Annual Meeting in Denver, from April 13 to 18, 2024.
April 12, 2024
·
8 min read
BioMidwest
UPSHER-SMITH LAUNCHES PITAVASTATIN TABLETS
Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of Pitavastatin Tablets in 1 mg, 2 mg, and 4 mg strengths.
November 6, 2023
·
1 min read
Deals
CDMO Bora Pharmaceuticals Buys Generics Manufacturer Upsher-Smith for $210M
Taiwanese contract development and manufacturing organization Bora will purchase Minnesota-based Upsher-Smith Laboratories, expanding operations into the U.S. for the first time.
January 18, 2024
·
2 min read
·
Tyler Patchen
BioMidwest
Upsher-Smith and the National Alliance of State Pharmacy Associations (NASPA) Announce Excellence in Innovation Award Recipients
Upsher-Smith Laboratories, LLC and the National Alliance of State Pharmacy Associations proudly announce the recipients of the 2023 NASPA Excellence in Innovation Award.
February 6, 2024
·
3 min read
BioMidwest
UPSHER-SMITH LAUNCHES FAMOTIDINE FOR ORAL SUSPENSION, USP
Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the recent launch of Famotidine for Oral Suspension, USP.
August 15, 2023
·
1 min read
Press Releases
UPSHER-SMITH TO FEATURE MULTIPLE PRESENTATIONS AT THE AMERICAN EPILEPSY SOCIETY (AES) 2024 ANNUAL MEETING
December 3, 2024
·
14 min read
1 of 71,581
Next
